Trading / Browse Companies / Eureka Therapeutics Stock

Eureka Therapeutics Stock

eurekatherapeutics.comHealthcareFounded: 2006Funding to Date: $52.37MM

Eureka Therapeutics is a biotechnology company focused on breakthrough immunotherapies for the treatment of cancer.

Buy or sell Eureka Therapeutics stockLearn more about Eureka Therapeutics IPO
Register for Details

For more details on financing and valuation for Eureka Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Eureka Therapeutics.

Register Today

Team

Management Team

Cheng Liu Ph.D
Founder, President, Chief Executive Officer and Board Member
Jingyi Xiang Ph.D
Head, Bioanalytics
Yiyang Xu Ph.D
Head, Phage display
Vivien Chan Ph.D
Head, Portfolio Management

Board Members

Cheng Liu Ph.D
Hsing-Jien Kung Ph.D
Wai-Yan Chau
Bruce Ames
Peter Lee MD
Wei Zhou Ph.D
Chih-Kai Cheng
Harbinger Venture Management
Michael Cannon
Qiushi Fu
Hsing Kung Ph.D
Acorn Campus Ventures

Other companies like Eureka Therapeutics in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
OURA
Sector
Healthcare
 
 
Headspace
Sector
Healthcare
Last Round Est. Valuation
$317.32MM
NowRx
Sector
Healthcare
Last Round Est. Valuation
$334.19MM
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
GoForward
Sector
Healthcare
Last Round Est. Valuation
$1.59B
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
VillageMD
Sector
Healthcare
 
 

Trending Companies

Frequently Asked Questions